ArticleEuropean radiology2024
Discrimination between HER2-overexpressing, -low-expressing, and -zero-expressing statuses in breast cancer using multiparametric MRI-based radiomics.
Shaoyan Zheng et al.PubMed ↗Publisher ↗
No numbers read from the abstract.
36 papers cite it
this papercites it